Interim Management Statement on the First Three Months of 2019
- Partner Link Health receives approval to conduct clinical trials with ESUPRON® in China
- Poster presentation at the AACR Annual Meeting 2019
- Financials have developed in line with planning
Heidelberg Pharma AG today reported on the first three months of fiscal year 2019 (1 December 2018 – 28 February 2019) and the Group’s financial figures.